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Alkaline nuclease, a relatively abundant viral phosphoprotein in herpes simplex virus type 1 (HSV-1)- or HSV-2-infected
cells, is encoded by a 2.3-kb mRNA (R. H. Costa, K. G. Draper, L. Banks, K. L. Powell, G. Cohen, R. Eisenberg, and E. K.
Wagner, 1983. J. Virol. 48, 591–603). This mRNA is a member of a family of five unspliced 3*-coterminal messages. Costa
et al. proposed that another member of this family of mRNAs (1.9-kb) may encode an N-terminally truncated protein which
shares its carboxy-terminus with the alkaline nuclease protein. We previously described the isolation of AN-1, a deletion/
insertion mutant of the alkaline nuclease gene (S. K. Weller, R. M. Seghatoleslami, L. Shao, D. Rowse, and E. P. Carmichael,
1990. J. Gen. Virol. 71, 2941–2952). The deletion in AN-1 would be predicted to abolish gene products of both the 2.3- and
the 1.9-kb mRNAs. To investigate whether the putative truncated version of alkaline nuclease encoded by the 1.9-kb mRNA
has enzymatic activity and plays a role in the viral life cycle, a viral mutant (AN-F1) was constructed which is predicted to
abolish the gene product of the 2.3-kb mRNA (full-length alkaline nuclease) but leave intact the putative product of the 1.9-
kb mRNA. Using a highly sensitive polyclonal antiserum raised against a bacterially expressed full-length alkaline nuclease,
we observed a 60-kDa protein in KOS- and AN-F1-infected cells but not in AN-1-infected cells. This suggests that the 60-
kDa protein is likely to be expressed from the 1.9-kb mRNA; the open reading frame is now designated UL12.5. Despite
the presence of the 60-kDa band, AN-F1 failed to exhibit any alkaline exonuclease activity. This result suggests that the
truncated polypeptide (UL12.5) is not enzymatically active, has low levels of activity, or possesses enzymatic activity which
is not detected because of the low abundance of the polypeptide. AN-1 and AN-F1 are both severely restricted with respect
to growth in Vero cells, as viral yields are 100- to 1000-fold lower than those of wild-type virus. We previously reported
that the major defect in AN-1 is in the ability of DNA-containing capsids which form in the nucleus to mature into the
cytoplasm (L. Shao, L. M. Rapp, and S. K. Weller, 1993. Virology 196, 146–162); AN-F1 exhibits the same defect. These
results indicate that although the 1.9-kb mRNA encodes a 60-kDa protein presumably from the UL12.5 open reading frame,
this polypeptide cannot substitute for the full-length UL12 product. q 1996 Academic Press, Inc.
INTRODUCTION The defect in AN-1 is distinct from that observed in
cleavage/packaging mutants of HSV-1 which make butThe UL12 gene of herpes simplex virus type 1 (HSV-
fail to process viral DNA under nonpermissive growth1) encodes an enzyme, alkaline nuclease, a relatively
conditions (Shao et al., 1993). Specific terminal fragmentsabundant phosphoprotein in infected cells with an appar-
are observed at near wild-type efficiency. Also, in con-ent molecular weight of 85 kDa (Banks et al., 1983, 1985).
trast to cells infected with cleavage/packaging mutants,This enzyme has been purified from infected cell extracts
DNase I or staphylococcal nuclease resistant DNA isand shown to exhibit exo- and endonuclease activities
observed in the nucleus of AN-1-infected cells, furtherwith a high pH optimum (Francke et al., 1978; Hoffmann,
indicating that cleavage and encapsidation have oc-1981; Hoffmann and Cheng, 1978; Strobel-Fidler and
curred. Despite the ability of AN-1 to cleave and encapsi-Francke, 1980). We previously reported the isolation of a
date DNA in the nucleus, three lines of evidence suggestnull mutant, AN-1, which fails to exhibit alkaline nuclease
that maturation of DNA-containing capsids is defectiveactivity in infected cells. This mutant induces near wild-
(Shao et al., 1993). First, in contrast to wild type, verytype levels of viral DNA synthesis and late proteins (Wel-
small amounts of protected DNA were detected in cyto-ler et al., 1990). However, AN-1 forms tiny plaques on
plasmic extracts from AN-1-infected cells. Second, theVero cells, and mutant virus yields in nonpermissive cells
intracellular capsid forms (A, B, and C) seen in AN-1-are reduced approximately 100- to 1000-fold compared
infected cells differ significantly from wild type. Type Awith those of wild-type virus.
or empty capsids are found in the nucleus and lack any
internal structures. A capsids are believed to arise from1 Present address: Department of Internal Medicine, University of
abortive, unsuccessful attempts to package viral DNATexas, Southwestern Medical Center, Dallas, TX 75235.
(Addison et al., 1990; Lee et al., 1988; Sherman and Bach-2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (203) 679-1239. E-mail: Weller@panda.uchc.edu. enheimer, 1988). Type B capsids, also found in the nu-
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cleus, exhibit internal structural features and contain a MATERIALS AND METHODS
protein (encoded by UL 26.5) known as the assembly
Cells and virusesor scaffold protein; type B capsids are believed to be
precursors to the DNA-containing C capsids found in the African green monkey kidney cells (Vero, ATCC) were
cytoplasm (Irmiere and Gibson, 1983, 1985). In AN-1- grown and maintained as described previously (Weller
infected cells, very few if any mature, DNA-containing C et al., 1983). The cell line 6-5, which is permissive for nuc
capsids were observed in the cytoplasm when analyzed mutants, was generated and maintained as previously
by electron microscopy or sucrose gradient sedimenta- described (Shao et al., 1993). The KOS strain of HSV-1
tion. Moreover, analysis by sucrose gradient sedimenta- was used as the wild-type virus. Nuc mutants AN-1 and
tion indicated an elevated ratio of A to B capsids relative AN-2 were described (Weller et al., 1990). AN-1-2a is a
to wild type. Taken together, these data indicate that AN- recombinant generated by the rescue of the AN-1 null
1 is defective in the production of capsids competent to mutation with a BamHI to HindIII fragment from pSG10-
mature into the cytoplasm. We have proposed that this BD2 (Weller et al., 1990). AN-F1, AN-F2, and AN-F3 are
defect is caused by the inability of AN-1 to resolve or frameshift mutants described in this article. They repre-
‘‘debranch’’ recombination intermediates which are sent three independent viral isolates of a mutation de-
formed during the DNA replication process (Shao et al., signed to introduce a 2-bp insertion at a position 14
1993; Weller et al., 1990). nucleotides from the N-terminus of the wild-type alkaline
The experiments reported in this paper were under- nuclease gene.
taken to resolve a long-standing question about the size
Plasmids and bacteriaand structure of the alkaline nuclease mRNA. The alka-
line nuclease gene corresponds to the leftward oriented
Plasmid pSG10 containing the EcoRI D fragment ofUL12 open reading frame and its message has been
HSV-1 strain KOS (map coordinates 0.086–0.194),mapped to a 2.3-kb member of a family of unspliced
pSG10-BD2 containing the BamHI–HindIII fragment3*-coterminal mRNAs comprising five partially colinear
(map coordinates 0.165–0.186) from pSG 10, and pAN-species (0.9-, 1.9-, 2.3-, 3.9-, and 4.5-kb) (Costa et al.,
1 containing a 917-bp deletion and a lacZ insertion in1983; Draper et al., 1986). The 0.9-, 3.9-, and 4.5-kb RNA
the alkaline nuclease gene were described previouslyspecies correspond to UL11, UL13, and UL14, respec-
(Weller et al., 1987, 1990) (see Fig. 1). pBS-BD2 containstively (Costa et al., 1983; Draper et al., 1986; McGeoch
the same BamHI–HindIII fragment as pSG10-BD2 in theet al., 1986, 1988). The putative cap site of the 1.9-kb
vector Bluescribe (pBS/) (Stratagene, San Diego, CA).mRNA species was mapped by Costa et al. Downstream
The BamHI–HindIII fragment from pSG10-BD2 was sub-from the cap site are two potential initiator ATG codons;
cloned into M13mp19 (M13-BD2) for use in oligonucleo-both are in-frame with the UL12 open reading frame. The
tide-directed mutagenesis. pTZDN7 containing a 2.3-kbclosest one, 131 bases downstream of the cap site,
BamHI–BstEII fragment (map coordinates 0.165–0.180)would be predicted to encode a 500-amino-acid polypep-
in the vector pTZ19U (U.S. Biochemicals) was generouslytide about 130 aa shorter than alkaline nuclease (Costa
provided by Dr. D. Parris (Columbus, OH). pTZDN7-LS iset al., 1983; Draper et al., 1986; McGeoch et al., 1986).
a subclone of pTZDN7 containing the BalI to BstEII frag-Costa et al. used hybrid selection to size fractionate and
ment of UL12 (see Fig. 1). Plasmids pSG10-P5 and -P6translate the 2.3- and 1.9-kb mRNAs from infected cells.
containing PstI fragments were described previouslyThe 2.3-kb mRNA generated an 82-kDa protein which
(Carmichael et al., 1988). Plasmid pUC119-AK containswas reactive with a monoclonal antibody (Q1) generated
a 3.2-kb SphI fragment from pSG10 (coordinates 0.161–against the alkaline nuclease (Banks et al., 1983, 1985).
0.183) ligated into the SphI site of pUC119 (Vieira andThe 1.9-kb mRNA generated a 60-kDa and a 54-kDa poly-
Messing, 1988) (see Fig. 1). pMMTV-LS contains the cod-peptide band, neither of which reacted with the Q1 anti-
ing region of the alkaline nuclease gene downstreamsera. The authors tentatively concluded that a polypep-
from an MMTV promoter. Plasmid pKBK, containing thetide may be encoded by this 1.9-kb mRNA. In this paper,
5.9-kb BamHI K fragment from strain KOS (BamHI K iswe describe the isolation and characterization of a mu-
equivalent to the BamHI SQ junction fragment), was gen-tant in alkaline nuclease (AN-F1) which is predicted to
erously provided by Dr. Neal DeLuca (University of Pitts-abolish the gene product of the 2.3-kb mRNA species
burgh, Pittsburgh, PA). Recombinant plasmids were prop-but leave intact the putative gene product of the 1.9-kb
agated in Escherichia coli UT481 or DH5a by standardmRNA. A 60-kDa protein which reacts with a sensitive
procedures (Maniatis et al., 1982).alkaline nuclease antibody can be detected in cells in-
fected with AN-F1 but not AN-1. This protein is likely Oligonucleotide-directed mutagenesis
encoded by the 1.9-kb mRNA expressed in AN-F1, and
its open reading frame has now been designated UL12.5. Single-strand DNA was prepared from M13-BD2 viri-
ons as described (Messing, 1983). Site-directed muta-We demonstrate that UL12.5 cannot substitute for the
full-length UL12 gene product. genesis (Zoller and Smith, 1983) was performed with an
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FIG. 1. Physical map of the region of the HSV genome containing the alkaline nuclease gene. Beneath the diagram of HSV-1 DNA, the region
of HSV-1 DNA spanning the UL11, UL12, and UL13 open reading frames has been expanded to show the cleavage sites for AccI (Ac), BamHI (Ba),
BglII (Bg), BstEII (Bs), EcoRV (EV), HindIII (Hi), PvuII (Pv), and SphI (Sp). On the next four lines, the 0.9-, 1.9-, 2.3-, and 3.9-kb mRNAs encoding the
UL11, UL12.5, UL12, and UL13 open reading frames (respectively) are shown. In the next two lines are shown the BamHI–BssHII fragment used
as a probe in Northern blot analysis and the BalI–BstEII fragment used for marker rescue.
oligonucleotide designed to introduce a frameshifting 2 Virus growth
bp into the alkaline nuclease gene and create a new The plaquing efficiency of mutant and wild-type virus
BamHI site. The oligonucleotide (5* GGACATGCTG was determined by titrating virus stocks on Vero and
GGATCCTCCCGTGG 3*; the 2-bp insertion is double permissive 6-5 cells. Plaque sizes were determined us-
underlined, and the newly created BamHI site is under- ing an ocular micrometer. The efficiency of virus produc-
lined) was synthesized using a Cyclone DNA synthesizer tion for mutant and wild-type virus under permissive and
(Biosearch Inc., Burlington, MA). The M13 clone con- nonpermissive conditions was determined following in-
taining the mutation was designated M13-BD2/2. The fection at an m.o.i. of 1 PFU/cell. At 24 hr, virus progeny
EcoRI– HindIII fragment from M13-BD2/2 was cloned were harvested and titrated on permissive 6-5 cells.
into the vector pUC119 in order to verify the mutation by
DNA sequencing using Sequenase (United States Bio- Marker rescue and marker transfer
chemical, Cleveland, OH) according to the supplier’s in-
Marker rescue and marker transfer experiments were
structions.
performed as described (Goldstein and Weller, 1988b;
Zhu and Weller, 1992). For marker transfer, transfections
Isolation and Southern blot analysis of viral DNA were carried out in the S22 permissive cell line (Weller
et al., 1990) with M13-BD2/2, a plasmid containing a 2-
Infectious viral DNA was isolated from purified virions bp insertion. The 2.3-kb insert containing the BamHI–
as described (Goldstein and Weller, 1988b). DNA to be HindIII fragment was excised from M13-BD2/2 by diges-
analyzed by restriction enzyme digestion was isolated tion with BamHI and HindIII and phenol extracted and
as described above except samples were extracted three ethanol precipitated prior to transfection. For marker res-
to five times with phenol:chloroform:isoamyl alcohol cue of AN-F1, permissive 6-5 cells were cotransfected
(25:24:1), once with chloroform:isoamyl alcohol (24:1), with infectious AN-F1 DNA and various plasmids con-
and precipitated with ethanol. Plasmid or viral DNA was taining DNA from the region. The HSV fragment was
digested with restriction endonuclease(s) as directed by excised from each rescuing plasmid with the appropriate
the manufacturer, separated by agarose gel electropho- restriction enzymes, and DNA was phenol extracted and
resis in Tris–borate–EDTA buffer, and transferred to a ethanol precipitated prior to transfection. When cyto-
GeneScreen Plus nylon membrane (New England Nu- pathic effect was maximal, the virus was harvested and
clear Corp., Boston, MA) as recommended by the sup- titrated on 6-5 or Vero cells. Plaques were stained simul-
plier. Recombinant DNAs used as probes for hybridiza- taneously with neutral red and the chromagenic sub-
tion were labeled as described (Feinberg and Vogelstein, strate 5-bromo-4-chloro-3-indoyl-b-D-galactoside (Gold-
stein and Weller, 1988a).1983).
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Northern blot analysis followed by 0.21 SSC/0.1% SDS, 5 min at RT, repeated
twice).
Vero cells were infected at an m.o.i. of 5 and harvested
at 6 hr, in order to examine early (b) RNAs. Total cellular Immunoblotting of HSV-infected cell extracts
RNA was isolated using guanidine isothiocyanate (Ausu-
Vero and 6-5 cells were mock-infected or infected withbel et al., 1990). Briefly, infected cells were lysed in the
KOS or AN-1 at an m.o.i. of 5 PFU/cell. A UL11-specificplates using a denaturing solution of 4 M guanidine iso-
antiserum was generously provided by Dr. Bernard Roiz-thiocyanate, 25 mM sodium citrate, pH 7, 0.1 M 2-b-ME,
man (University of Chicago, Chicago, IL) (Baines et al.,and 0.5% laurylsarcosine. The homogenate was ex-
1995). This antiserum was generated in rabbits inocu-tracted with a mixture of water-saturated phenol, sodium
lated with a GST fusion protein containing the last 90 ofacetate, and 49:1 chloroform:isoamyl alcohol. The RNA
the 95 amino acids of UL11. Immunoblots using the anti-in the aqueous phase was precipitated once with isopro-
UL11 antiserum were performed as follows: cells werepanol, redissolved in denaturing solution, reprecipitated
harvested at 18 hr postinfection, centrifuged at 2000 rpmwith isopropanol, washed in 75% ethanol to remove ex-
for 5 min in a Beckman model TJ-6-table-top centrifuge,cess guanidine, and finally resuspended in DEPC-
and resuspended and rinsed in PBS (137 mM NaCl, 2.7treated, distilled deionized sterile water.
mM KCl, 10 mM Na2HPO4 , 1.8 mM KH2PO4 , pH 7.4). CellApproximately 5 mg of RNA was denatured by the gly-
pellets were resuspended in 400 ml PBS and 100 ml 51oxol/DMSO method and subjected to electrophoresis on
SDS–PAGE loading buffer (0.3125 M Tris 6.8, 10% SDS,1.0% agarose gels made in 10 mM sodium phosphate
50% glycerol, 25% BME, 0.001% bromphenol blue), boiledbuffer (Ausubel et al., 1990). Northern blotting was per-
for 3 min, sheared by passage through a 25-gauge nee-formed using GeneScreen Plus as recommended by the
dle and 1-cc syringe, boiled again for 3 min, and immedi-manufacturer. Blots were probed at 607 using the BssHII–
ately subjected to SDS–PAGE and immunoblotting asBamHI fragment of the wild-type alkaline nuclease gene
described (Weller et al., 1990).(see Fig. 1) and rinsed at low stringency (21 SSC/0.1%
A new polyclonal antiserum (BWp12) was generated inSDS, 5 min at room temperature (RT), repeated twice,
rabbits against full-length alkaline nuclease polypeptide
synthesized in E. coli. To isolate protein to inject into
rabbits for polyclonal antisera production, a recombinant
alkaline nuclease (rAE) isolated from bacterial cells
(Bronstein and Weber, manuscript in preparation) was
purified to homogeneity by electroelution from SDS–
PAGE gels. Up to 10 mg of rAE was loaded onto individ-
ual 8% SDS–PAGE gels. Following electrophoresis, the
gels were transferred into a fixing solution consisting of
25% v/v isopropanol and 10% v/v acetic acid. Due to the
abundant amount of protein loaded, opaque bands of
precipitated protein were visualized against a dark back-
ground without the need for further staining. An 86-kDa
band corresponding to the full-length rAE was excised
and transferred to an electroeluter (Bio-Rad Model 422).
SDS was removed by electroelution of the protein into
native electrophoresis buffer. Recovery of soluble protein
FIG. 2. Conserved motifs in alkaline nuclease genes from eight differ- following this procedure was typically on the order of
ent herpesviruses. Seven conserved regions (labeled I–VII) have been
10–20%. Approximately 5 mg of the recovered rAE waspredicted based on amino acid sequences of alkaline nuclease genes
sent to Rockland, Inc. (Gilbertsville, PA) for custom poly-from different herpesviruses (Glenda Moore, personal communication).
Each line depicts an alkaline nuclease homologue from a different clonal antibody production. An additional 20 mg of rAE
herpesvirus, and the numbers of amino acid residues in each predicted was also shipped to Rockland, Inc. for creation of a pro-
open reading frame are shown. Virus abbreviations are as follows: tein-coupled affinity column for purification of the poly-
HSV, herpes simplex virus; EHV, equine herpesvirus; VZV, varicella–
clonal antisera generated. Western blots with BWp12zoster virus; HVS, herpesvirus Saimiri; EBV, Epstein–Barr virus; HHV-
were performed as follows: Vero cells were grown over-6, human herpesvirus type 6; HCMV, human cytomegalovirus. The con-
served motifs have been marked I through VII and are designated by night, inoculated with fresh media containing HSV-1
a black box whose width is roughly proportional to the length of each (strain KOS) or its mutant derivatives at an m.o.i. of 10
conserved motif. Wider boxes do not designate a higher level of overall PFU/cell the following day, and harvested by scraping
homology. Overall homology levels were assessed by calculating the
and low-speed centrifugation at 18 hr postinfection. Thenumber of conserved residues per total number of residues in each
cell pellets were rinsed with phosphate-buffered salinemotif and are as follows: I, 11/26; II, 10/16; III, 12/15; IV, 11/32; V, 6/15;
VI, 14/20; and VII, 7/10. prior to storage at 0707. Cell pellets were lysed by the
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addition of loading buffer (125 mM Tris–HCl, 20% v/v (one-tenth of each sample) was removed for dot-blot
analysis to determine the amount of viral DNA synthesisglycerol, 2% w/v SDS, 25 mg/ml bromophenol blue, 5%
v/v b-mercaptoethanol) and heated to 1007 for 5 min. The as described previously (Gadler, 1983; Zhu and Weller,
1992). The radioactivity in individual spots on the dot-blotlysates were cleared by centrifugation and diluted such
that 1.5 mg of protein could be loaded onto 8% polyacryl- membrane was quantified on a Packard InstantImager
(phosphorimager). The rest of each sample was fraction-amide gels (NOVEX). Following SDS–PAGE, proteins
were transferred onto PVDF membranes using a NOVEX ated into nuclear and cytoplasmic fractions, treated with
staphylococcal nuclease (SN), and analyzed on discon-Western transfer apparatus (San Diego, CA). The re-
sulting blots were incubated with a 1:20,000 dilution of tinuous conventional agarose gels as described in Shao
et al. (1993).BWp12 antisera (80 ng/ml). Protein reactivity was detected
using a 1:5000 dilution of goat anti-rabbit alkaline phos-
phatase conjugated antibody (Promega, Madison, WI) and RESULTS
BCIP/NBT substrate (Kirkegaard & Perry Laboratories,
Isolation of frameshift mutants
Gaithersburg, MD). Expressions of full-length and minor
bands on immunoblots were quantified by measuring the These studies were undertaken to investigate whether
the 1.9-kb mRNA could produce an N-terminally trun-reflectance on blots containing HSV-1 (KOS) extracts
probed with BWp12 antisera using a Hoefer GS370 densi- cated version of UL12 with alkaline nuclease activity. A
frameshift mutant was isolated which would abolish thetometer. The areas under the peaks were measured.
full-length UL12 gene product encoded by the 2.3-kb
Alkaline nuclease assays mRNA without affecting the transcription or translation
of the 1.9-kb species (see Materials and Methods). A 2-Crude extracts from HSV-infected cells were prepared
essentially as described previously (Francke and Garrett, bp insertion at a position 14 nucleotides from the N-
terminal ATG of the nuclease gene was engineered1982; Weller et al., 1990). Exonuclease assays were per-
formed as described (Weller et al., 1990). which would result in the premature termination of trans-
lation of the 2.3-kb mRNA (a truncated protein of 15
Analysis of DNA cleavage in total and encapsidated DNA amino acids in length would be expected).
The 2-bp insertion mutation was introduced into theVero cells were infected with KOS, AN-1, AN-F1, AN-
F3, and AN-1-2a at an m.o.i. of 3 PFU/cell and incubated HSV-1 strain KOS genome by marker transfer. S22 cells
were cotransfected with M13-BD2/2 containing the 2-for 18 hr at 377. Cells on a 60-mm tissue culture dish
were scraped into the medium, washed once in TBS (25 bp insertion mutant and intact infectious DNA from the
blue plaque mutant AN-1. Clear plaques were pickedmM Tris-HCl, pH 7.4, 137 mM NaCl, 20 mM KCl), and
resuspended in 1 ml RSB (0.01 M Tris–HCl, pH 7.4, 0.01 from a background of blues, and three independent iso-
lates, AN-F1, AN-F2, and AN-F3, were chosen for furtherM KCl, 0.0015 M MgCl2). Samples were frozen and
thawed once and sonicated. Each sample was divided study. Southern blot hybridization with virion DNA derived
from each mutant was used to confirm that the 2-bpin two equal portions, one of which was treated with
DNase I at a final concentration of 50 mg/ml and incu- insertion was incorporated into the correct location,
since a new BamHI site is expected to be present in thebated for 2 hr at 377. Both aliquots, representing total
and DNase I resistant DNA, were lysed in 0.6% SDS, 10 mutants. DNAs from KOS, AN-F1, AN-F2, and AN-F3 or
mM EDTA, 10 mM Tris, pH 7.4, and 100 mg/ml proteinase
K at 377 for 3–4 hr. RNase was added to 100 mg/ml and
the samples were incubated at 377, for 30 min. DNA
was then extracted and precipitated as described above.
Following digestion with BamHI, total and encapsidated
DNAs (DNase I resistant) were analyzed by agarose gel
electrophoresis on conventional 0.8% agarose gels. Gels
were subjected to Southern blotting as described above,
and filters were probed with a 32P-labeled BamHI SQ
junction fragment which detects both termini (Bam S and
Q) and junction (Bam SQ) fragments. The radioactivity in
individual BamHI fragments on the Southern blot was FIG. 3. Southern analysis of HSV-1 strain KOS and virus AN-F1, AN-
F2, and AN-F3 DNA. DNAs from HSV-1 strain KOS (lane 1) and virusquantified on a Packard InstantImager (phosphorimager).
AN-F1 (lane 4), AN-F2 (lane 5), and AN-F3 (lane 6) were digested with
Cell fractionation and staphylococcal nuclease BamHI and HindIII and subjected to gel electrophoresis in parallel with
BamHI–HindIII-digested pBS-BD2 (lane 2) and M13-BD2/2 (lane 3).digestion
DNAs were separated on a 0.8% agarose gel, blotted onto GeneScreen
Vero cells were infected with KOS and nuc mutants, Plus, and hybridized to the 32P-labeled BamHI–HindIII fragment from
pBS-BD2.AN-1 or AN-F1, at an m.o.i. of 5 for 18 hr at 377. An aliquot
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TABLE 1 TABLE 2
Plaquing Efficiencies of Mutant and Wild-Type Strains Virus Yields from Vero and 6-5 Cells Infected with Mutant
and Wild-Type Strains of HSV-1of HSV-1 on Vero and 6-5 Cells
Titer a (plaque size) Titer a
Virus Vero cells 6-5 CellsVirus Vero cells 6-5 cells
KOS 1.2 1 108 (1.0– 1.5 mm) 1.1 1 108 (1.0–1.5 mm) KOS 1.4 1 108 ({0.2 1 108) 1.4 1 108 ({0.2 1 108)
AN-1 1.5 1 105 ({0.4 1 105) 1.3 1 107 ({0.1 1 107)AN-1-2a 1.0 1 108 (1.0– 1.5 mm) 1.1 1 108 (1.0–1.5 mm)
AN-1 2.2 1 105 (0.25 mm) 1.0 1 107 (1.0–1.5 mm) AN-F1 1.2 1 105 ({0.3 1 105) 1.6 1 107 ({0.07 1 107)
AN-F3 1.4 1 105 ({0.2 1 105) 1.5 1 107 ({0.3 1 107)AN-F1 4.0 1 105 (0.25 mm) 1.0 1 107 (1.0–1.5 mm)
AN-F3 4.1 1 105 (0.25 mm) 1.5 1 107 (1.0–1.5 mm)
a Monolayers of Vero or 6-5 cells were infected at a multiplicity of 2
PFU/cell with HSV-1 strain KOS, AN-1, AN-F1, or AN-F3. At 24 hr virusa Plaquing efficiencies were determined by plating virus stocks on
monolayers of the indicated cell line and are given as PFU/ml. Plaque progeny were harvested and titrated on monolayers of 6-5 cells. The
means of three separate titers are given with standard errors.sizes were measured using a micrometer.
viruses in Vero cells were reduced approximately 1000-from double-stranded plasmids pBS-BD2 and M13-
fold compared with wild-type virus in Vero cells. As pre-BD2/2 (containing the wild-type and mutant versions of
viously reported for AN-1, the permissive cells cannotthe alkaline nuclease region, respectively) were purified,
fully compensate for the growth defects in AN-F1; thedigested with BamHI and HindIII, and subjected to gel
yields in 6-5 cells were reduced 10-fold compared toelectrophoresis and Southern blot hybridization as de-
those of strain KOS in the same cells. Taken together,scribed under Materials and Methods. Membranes were
these results indicate that the growth phenotypes of thehybridized to a 32P-labeled BamHI– HindIII fragment from
frameshift mutants, AN-F1 and AN-F3, are identical topSG10-BD2. KOS and pBS-BD2 DNA (Fig. 3A, lanes 1
that of the null mutant AN-1.and 2) contain the wild-type, 3.1-kb form of the BamHI –
HindIII fragment, whereas M13-BD2/2, AN-F1, AN-F2,
Marker rescueand AN-F3 (Fig. 3, lanes 3–6, respectively) contain the
2.0-kb fragment expected if an internal BamHI site was Marker rescue was performed to confirm that the
present. The 1.1-kb band was electrophoresed off the growth defects observed in AN-F1 were due to the
gel shown in Fig. 3; however, it was seen on other gels. frameshift mutation introduced into the nuclease gene.
These results demonstrate that the 2-bp insertion in M13- 6-5 cells were cotransfected with infectious AN-F1 DNA
BD2/2 did in fact lead to the introduction of a novel and the plasmids shown in Table 3, and progeny viruses
BamHI site at the expected position. were titered in Vero and 6-5 cells. Plasmids pSG10, pBS-
BD2, pTZDN7, and pTZDN7-LS were all able to rescue
Growth properties of AN-F1
The mutants AN-F1 and AN-F3 were compared to the TABLE 3
null mutant AN-1, recombinant AN-1-2a, and wild-type
Marker Rescue of AN-F1
strain KOS for their ability to form plaques in nonpermis-
sive Vero or permissive 6-5 cells. As indicated in Table Sequence Marker rescue
Plasmida Coordinatesb coordinatesc efficienciesd1, the plaquing efficiency of AN-F1 and AN-F3 on Vero
cells is comparable to AN-1 and is considerably lower
pSG10 0.086–0.194 12,593–29,338 41than that of KOS or recombinant AN-1-2a. As was pre-
pBS-BD2 0.165–0.186 24,890–27,986 16.5
viously noted for AN-1, plaques of AN-1, AN-F1, and AN- M13–BD2/2 0.165–0.186 24,890–27,986 0.05e
F3 on Vero cells are very small (less than 0.25 mm in pTZDN7 0.165–0.180 24,890–27,265 11.8
pTZDN7-LS 0.174–0.180 26,405–27,265 18.5diameter) compared to those of KOS and AN-1-2a (1.0 –
pSG10-P6 0.151–0.158 22,479–23,653 0.051.5 mm in diameter) and have an unusual morphology,
None 0.05being asymmetrical instead of round. AN-1, AN-F1, and
AN-F3 form plaques efficiently on 6-5 cells. To test further a Plasmids were linearized, extracted twice with phenol:chloro-
the growth properties of the frameshift mutants in Vero form:isoamyl alcohol (25:24:1), and ethanol-precipitated before trans-
fection.and 6-5 cells, cells were infected at a multiplicity of infec-
b Coordinates are in the P orientation.tion of 2 PFU per cell with KOS, AN-1, AN-F1, or AN-
c Sequence coordinates are taken from strain 17 (McGeoch et al.,F3, harvested at 24 hr postinfection, and yields were
1988).
determined in permissive 6-5 cells (Table 2). The yields d Results are expressed as plating efficiencies, which were deter-
of AN-F1 and AN-F3 virus in both 6-5 and Vero cells are mined using the formula [(PFU/mlVero)/PFU/mlS22)] 1 103.
e Numbers in italics were considered negative for marker rescue.comparable to those seen for AN-1. Yields of nuc mutant
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the growth defect in AN-F1. The smallest fragment which UL12, a putative N-terminal truncation of UL12, and UL11,
respectively (Costa et al., 1983). The 32P-labeled BamHI–can rescue the lesion in AN-F1 is the 865-bp BalI to
BstEII fragment from pTZDN7-LS (see Fig. 1); this frag- BssHII fragment is predicted to react with all five mem-
bers of this family. As seen in Fig. 4, lanes 1 and 3, cellsment spans the N-terminus of UL12 and extends to within
the coding sequences of the UL13 gene by 315 nucleo- infected with wild-type KOS or the wild-type recombinant
AN-1-2a contain all five predicted mRNA species (in ourtides. Although it is possible that the defects of the
frameshift mutants are due to spontaneous mutation gels the band reported to be 4.5 kb ran as 4.4 kb). As
expected, in cells infected with AN-1 (Fig. 4, lane 2),within the UL13 gene, this is highly unlikely for two rea-
sons. First, AN-F1 and AN-F3 were isolated indepen- neither the 2.3- nor the 1.9-kb mRNA species are seen.
A band larger than 4.4 kb is seen which could representdently and exhibit identical phenotypes, and we consider
it unlikely that both would contain spontaneous muta- one or more RNA species. AN-1 was created by first
deleting 917 bp from the alkaline nuclease gene andtions in UL13. Second, both AN-F1 and AN-F3 are sup-
ported by the cell line 6-5 which is not predicted to en- then inserting the 4.2-kb ICP6::lacZ cassette; this con-
struct would therefore be expected to add approximatelycode the UL13 ORF (Tables 1 and 2). Thus, the growth
defects of AN-F1 and AN-F3 are likely due to the engi- 3.3 kb to all the 1.9-, 2.3-, 3.9-, and 4.4-kb mRNAs. The
UL11 mRNA (0.9-kb) should be unaffected since its pro-neered frameshift mutations in the N-terminus of the
UL12 gene. moter is downstream from the position of the deletion/
insertion; this is confirmed in Fig. 4 (lane 2). An RNA
species slightly larger than 0.9 kb is seen in AN-1-in-Analysis of mRNA species from the alkaline nuclease
fected cells and is of unknown origin. Cells infected withfamily
the frameshift mutant AN-F1 contain the same species
The mutations in the frameshift mutants were de- of RNA as seen in KOS- and AN-1-2a-infected cells, al-
signed to abolish translation of the 2.3-kb mRNA but to though the bands are fainter because less RNA was
leave intact the 1.9-kb mRNA and its putative open read- loaded on the gel (Fig. 4, lane 3). The fact that the 2.3-
ing frame, UL12.5. To confirm that the predicted mRNAs and 1.9-kb species are present in AN-F1-infected cells
were still transcribed by AN-F1, Northern blot analysis confirms the prediction that the transcripts in AN-F1 are
was carried out on extracts from KOS-, AN-1-, AN-F1-, not altered by the introduction of the frameshift mutation.
and the wild-type recombinant AN-1-2a-infected Vero
cells as described under Materials and Methods (Fig. 4). Analysis of proteins encoded by the alkaline nuclease
The members of the 3*-coterminal family of mRNAs are family of mRNAs
4.4-, 3.9-, 2.3-, 1.9-, and 0.9-kb encoding UL14, UL13,
Costa et al. suggested that a 54-kDa truncated form
of alkaline nuclease, corresponding to amino acids 130–
626, would be expected from the 1.9-kb mRNA species
(Costa et al., 1983). Hybrid selection experiments gener-
ated two bands (54- and 60-kDa) by in vitro translation
(Costa et al., 1983); however, two 1.9-kb mRNAs were
present in the starting material, one from each strand.
Neither of these proteins reacted with the Q1 monoclonal
antibody which was raised against the HSV-2 alkaline
nuclease but reacts also with the alkaline nuclease from
HSV-1 (Banks et al., 1983, 1985). Thus, it has never been
clear whether the 1.9-kb member of the alkaline nuclease
family of mRNAs actually encodes a protein. To deter-
mine whether AN-F1 was capable of expressing a trun-
cated form of the nuclease, extracts from Vero cells in-
fected with KOS, AN-1, AN-F1, or AN-F3 were subjected
FIG. 4. Northern analysis of HSV-1 strain KOS, AN-1, AN-1-2a, and to SDS–PAGE in a 8% acrylamide gel and immunoblotted
AN-F1 RNAs. Vero cells were infected with KOS, AN-1, AN-1-2a, or AN-
with a new antibody, BWp12. BWp12 was raised by in-F1. Total RNA was harvested at 6 hr postinfection by guanidinium
jecting rabbits with a purified full-length alkalineisothiocyanate, denatured in glyoxol/DMSO, and separated on a 1%
agarose gel as described under Materials and Methods. RNAs were nuclease polypeptide expressed in bacteria (Bronstein
blotted onto GeneScreen Plus and hybridized to a 32P-labeled BamHI– and Weber, submitted for publication). BWp12 was found
BssHII fragment (see Fig. 1). Lane 1, RNA from KOS-infected Vero cells; to exhibit lower levels of background staining than the
lane 2, RNA from AN-1-infected Vero cells; lane 3, RNA from AN-1-2a-
previously used polyclonal antibody, R241 (Shao et al.,infected Vero cells; and lane 4, RNA from AN-F1-infected Vero cells.
1993). Mock-infected cells do not react with BWp12, indi-28 and 18S rRNA served as size markers, and approximate sizes of
viral mRNA species are shown as described (Costa et al., 1983). cating the high degree of specificity of this antibody (Fig.
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represents less than 10% (actual values, 9.9, 7.8, and
9.4%) of the level of full-length alkaline nuclease protein,
although the levels of mRNA are roughly equivalent. This
may be due to the fact that the AUG for UL12.5 is in a
less optimal context for translation than is the AUG for
UL12 (Kozak, 1987).
The mutation AN-1 was designed so that it would not
affect the open reading frames for neighboring genes
UL11 and UL13. However, in light of recent reports dem-
onstrating that the deletion of a large portion of UL11
resulted in a virus which exhibited a defect in egress from
cells (Baines et al., 1995; Baines and Roizman, 1992),
we tested KOS- and nuc mutant-infected cells for the
presence of UL11. Extracts from monolayers of Vero cells
infected with KOS, AN-1, AN-1-2a, AN-F1, or mock-in-
fected were prepared for immunoblotting as described
under Materials and Methods and anti-UL11 antiserum,
generously provided by Dr. B. Roizman, was used. In all
infected cell extracts (Fig. 6, lanes 2–5), bands with the
FIG. 5. Immunoblots of extracts from KOS-, AN-1-, AN-F1-, AN-F3 expected mobility of UL11 (17–22K) which reacted with
and mock-infected Vero and 6-5 infected cells. Monolayers of Vero the antiserum were observed, whereas no such bands
cells were infected with KOS, AN-1, AN-F1, or AN-F3 or were mock-
were seen in mock-infected extracts (Fig. 6, lane 1). Thusinfected. Extracts were prepared at 18 hr postinfection as described
it appears that none of the nuc mutants have a defect inunder Materials and Methods and resolved by SDS–PAGE and reactive
proteins revealed by Western blotting with the BWp12 antibody. Sample the synthesis of the UL11 gene product.
preparation and immunoblotting were performed as described under
Materials and Methods. Lanes from left to right represent mock-, KOS-,
Alkaline nuclease activityAN-F3-, AN-F1-, and AN-1-infected Vero cells.
Extracts of wild-type- and mutant-infected Vero cells
were assayed for alkaline nuclease activity as described5, lane labeled mock). KOS-infected cell extracts express
under Materials and Methods. Table 4 shows that likea major band of 86 kDa (labeled 86K alk nuc) and two
mock- and AN-1-infected extracts, AN-F1- and AN-F2-minor bands corresponding to 81- and 60-kDa proteins
infected cell extracts do not exhibit significant amounts of(Fig. 5, lane labeled KOS). The presence of a slightly
smaller than full-length alkaline nuclease protein (81-
kDa) is consistent with earlier reports on nuclease puri-
fied from infected cells (Strobel-Fidler and Francke,
1980). The 60-kDa band (labeled 60K, UL12.5) could rep-
resent either a degradation product or an N-terminally
truncated product of the 1.9-kb mRNA. Cells infected with
AN-1 do not contain any immunoreactive proteins as
would be expected considering the large deletion (Fig.
5, lane labeled AN-1). In contrast, cells infected with AN-
F1 and AN-F3 contain the 60-kDa band (Fig. 5, lanes
labeled AN-F1 and AN-F3). The fact that the 60-kDa band
is present in cells infected with AN-F1 and AN-F3 sug-
gests that it is a product of the 1.9-kb mRNA and not a
breakdown product of the larger 80- to 86-kDa polypep-
tides. The 60-kDa band was not observed when immu-
noblots were reacted with the monoclonal antibody (data
not shown). Thus, Q1 may recognize a conformational FIG. 6. Immunoblots of extracts from KOS-, AN-1-, AN-1-2a-, AN-F1-,
epitope only present in full-length UL12 or the epitope and mock-infected Vero cells reacted with a UL11 antiserum. Extracts
from monolayers of Vero cells infected with KOS, AN-1, AN-1-2a, AN-F1may reside within the N-terminal 120 aa. The intensity of
(5 PFU/cell), or mock-infected were prepared as described under Materialsthe 60-kDa band (designated UL12.5) on three separate
and Methods. The anti-UL11 antisera was used to reveal reactive proteins.Western blots were compared to that of the full-length
Lane 1, mock-infection; lane 2, KOS; lane 3, AN-1; lane 4, AN-1-2a; lane
band described under Materials and Methods. The areas 5, AN-F1. Bands which migrate at the position expected for UL11 are
under the peaks for the full-length nuclease and UL12.5 marked to the right. The positions of molecular weight markers are shown
to the left.were determined. In each case the level of UL12.5 protein
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TABLE 4 variability was observed. Overall, levels of viral DNA syn-
thesis by AN-1 and AN-F1 are between 60 and 90% ofAlkaline Nuclease Activity in Cells Infected
the levels seen in KOS-infected cells. Although AN-1-2awith KOS, AN-1, AN-F1, or AN-F2
behaves as wild type, some variability in levels of DNA
% Wild-type synthesis are also seen (80–95%). Thus no gross defect
Virus cpm 3H releaseda activity in overall viral DNA synthesis was observed in any of
the nuc mutants.AN-1 46 3.7
AN-F1 42 3.3
AN-F2 60 4.7 Cleavage and encapsidation of viral DNA
KOS 1965 100
The ability of the frameshift mutants AN-F1 and AN-
a 3H cpm rendered acid soluble from labeled DNA by crude extract F3 to process viral DNA was analyzed as previously de-
corresponding to approximately 50 mg of cellular protein corresponding scribed (Shao et al., 1993). Total and DNase-1-resistantto 1.251 106 cells during 30 min at 377. Approximately 2000 cpm would
DNA from wild-type- and mutant-infected cells was ana-be expected to be released for each reaction shown. 3H cpm liberated
lyzed by BamHI digestion and Southern blot hybridizationfrom mock-infected cell extracts were subtracted from each value.
as described under Materials and Methods. Only viral
DNA which had undergone terminal cleavage would be
exonuclease activity, whereas KOS-infected cell extracts expected to exhibit terminal BamHI fragments S and Q,
exhibit considerable activity under these reaction condi- whereas high-molecular-weight replication concatemers
tions. This result indicates that like AN-1, frameshift mu- would be expected to contain predominantly the junction
tants AN-F1 and AN-F2 are incapable of inducing alkaline fragment SQ. Consistent with our previous results, S and
nuclease activity above levels obtained from mock-in- Q fragments are seen in the total DNA samples from
fected cell extracts. However, we cannot rule out that the Vero cells infected with KOS, AN-1, and AN-1-2a (Fig. 7,
1.9-kb mRNA encodes a protein with very low exo- lanes 2, 4, and 6, respectively). An identical pattern was
nuclease activity or with endonuclease activity which is observed in cells infected with AN-F1 or AN-F3 (Fig. 7,
not detected in this assay. Since the 60-kDa protein lanes 8 and 10). The efficiency of cleavage by each virus
(UL12.5) is only present at 10% the levels seen of the was determined by comparing the amounts of DNA in
full-length UL12 gene product, low levels of activity may the BamHI S band from KOS-, AN-1-, AN-1-2a-, AN-F1-,
not have been detected. and AN-F3-infected cells after normalization for the total
amount of viral DNA synthesis as described previouslySynthesis of viral DNA
We previously reported that mutant AN-1 was able to
synthesize between 50 and 90% wild-type levels of viral
DNA as assessed by dot-blot hybridization (Shao et al.,
1993). In the experiments shown in Table 5, the ability
of KOS, AN-1, AN-1-2a, AN-F1, or AN-F3 to synthesize
viral DNA was measured by dot-blot hybridization of total
DNA from infected cells to a virus-specific probe (see
Materials and Methods). As before, a great degree of
TABLE 5
Viral DNA Synthesisa
Virus Experiment 1b Experiment 2b Experiment 3c
FIG. 7. Southern blot analysis of total and encapsidated (DNase-I-
resistant) DNA from KOS, AN-1, AN-1-2a, AN-F1 and AN-F3. Vero cellsKOS 100% 100% 100%
AN-1 87% 84% 68% were infected with the indicated virus at an m.o.i. of 3 PFU/cell. At 18
hr postinfection, either total or encapsidated (DNase-I-resistant) DNAAN-1-2a 95% 78% 80%
AN-F1 80% 62% 81% was isolated as described under Materials and Methods. Lanes with
DNase I (/) represent the encapsidated DNA and lanes without DNase
I (0) represent total DNA. DNAs were digested with BamHI, subjecteda Infected cells were harvested at various times postinfection and
viral DNA levels were determined by dot-blot analysis as described to electrophoresis, and transferred to a Genescreen Plus membrane.
Membranes were probed with a 32P-labeled BamHI SQ junction frag-under Materials and Methods (Gadler, 1983; Zhu and Weller, 1992).
Values are expressed as a percentage of wild type, set at 100%. ment. Lane 1, KOS DNA isolated from virions; lanes 2 and 3, KOS-
infected Vero cells; lanes 4 and 5, AN-1-infected Vero cells; lanes 6b Infected cells were harvested at 18 hr postinfection at an m.o.i. of
3 PFU/cell. and 7, AN-1-2a-infected Vero cells; lanes 8 and 9, AN-F1-infected Vero
cells; and lanes 10 and 11, AN-F3-infected Vero cells. Radioactivityc Infected cells were harvested at 13 hr postinfection at an m.o.i. of
3 PFU/cell. was quantified on a Packard InstantImager (phosphorimager).
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(Shao et al., 1993). In this experiment, AN-1, AN-1-2a,
AN-F1, and AN-F3 exhibited 68, 86, 59, and 54% wild-
type levels of viral DNA. Cleavage in AN-1, AN-1-2a-, AN-
F1-, and AN-F3-infected cells is approximately 103, 87,
132, and 100% as efficient as wild type, respectively. Thus
it is clear that nuc mutants are able to carry out specific
genomic cleavage as efficiently as wild-type virus.
The ability of HSV to encapsidate DNA was assessed
by treating infected cells with deoxyribonucleases (either
DNase I or SN). In the experiment shown in Fig. 7, encap-
sidated (DNase-I-resistant) DNA was analyzed. Signifi-
cant amounts of DNA from KOS-, AN-1-, AN-1-2a-, AN-
F1-, and AN-F3-infected cells are seen in the DNase-
treated lanes (Fig. 7, lanes 3, 5, 7, 9, and 11, respectively),
indicating that packaging has occurred. If cleavage and
packaging are linked processes as has been suggested
(Ladin et al., 1980, 1982), one would expect that the
amount of terminal fragment S in total and DNase-I-
treated DNA samples would be approximately equal. We
FIG. 8. Staphylococcal nuclease digestion analysis of viral DNA. Vero
previously found that this was the case for cells infected cells infected with KOS, AN-1, or AN-F1 at an m.o.i. of 3 PFU/cell for
with KOS or with the recombinant virus AN-1-2a. How- 18 hr at 377 were fractionated into nuclear (N) and cytoplasmic (C)
fractions and analyzed by sensitivity to staphylococcal nuclease essen-ever, the amount of DNA in the S band in the DNase-I-
tially as described (Lentine and Bachenheimer, 1990). DNA samplestreated sample from AN-1-infected Vero cells was less
were subjected to electrophoresis on a discontinuous agarose gel asthan that in the total DNA sample (Shao et al., 1993). We
described (Lentine and Bachenheimer, 1990); the upper third of the gel
suggested that the encapsidated DNA in mutant-infected was 0.6% agarose and the lower two-thirds were 2% agarose. The DNA
cells may be unstable to extraction, leading to poor re- was transferred to a GeneScreen Plus nylon membrane and probed
with the 32P-labeled BamHI SQ junction fragment. Lane 1 representscovery of DNase-I-protected DNA. Figure 7 shows that
KOS DNA isolated from virions; lanes 2 and 3, KOS-infected Vero cells;AN-F1 and AN-F3 (lanes 9 and 11) behave in a manner
lanes 4 and 5, AN-1-infected Vero cells; and lanes 6 and 7, AN-F1-identical to AN-1 (lane 5).
infected Vero cells.
In cells infected with wild-type HSV-1, nuclease-resis-
tant, genomic-length DNA can be detected in both the
nucleus and the cytoplasm, since DNA-containing cap- Although SN-resistant DNA is seen in the nucleus of AN-
sids form in the nucleus and proceed to mature into the 1- and AN-F1-infected cells, no detectable SN-resistant
cytoplasm. In Vero cells infected with the null mutant AN- DNA is seen in the cytoplasm (Fig. 8, lanes 5 and 7,
1, significant amounts of SN-resistant DNA were ob- respectively). These results indicate that like the AN-1
served in the nucleus; however, very little SN-resistant null mutant, the frameshift mutants fail to mature effi-
DNA could be found in the cytoplasm (Shao et al., 1993). ciently into the cytoplasm.
Thus the major defect in AN-1 was in the ability of cap- We previously reported that AN-1 demonstrated an
sids to egress from the nucleus into the cytoplasm. In abnormally high level of A capsids and no C capsids
order to determine whether the frameshift mutants exhib- (Shao et al., 1993). Vero cells infected with wild-type KOS,
ited a similar phenotype, nuclear and cytoplasmic frac- AN-1, or AN-F1 were analyzed by sucrose gradient cen-
tions from cells infected with KOS, AN-1, and AN-F1 were trifugation (Gibson and Roizman, 1972). Identical distribu-
analyzed. Each fraction was digested with SN, and DNA tions of intracellular capsids were observed in AN-1 and
was isolated and subjected to discontinuous gel electro- AN-F1 in that no C capsids were observed. Furthermore,
phoresis. Viral DNA was visualized after transfer to nylon elevated ratios of A to B capsids were seen in AN-F1-
filters and hybridization with 32P-labeled BamHI SQ frag- infected cells (data not shown).
ment (Fig. 8). Undigested virion DNA migrated as a single
large band (Fig. 8, lane 1). SN digestion of nuclear frac- DISCUSSION
tions from KOS-infected Vero cells resulted in the appear-
ance of resistant and sensitive forms of viral DNA (Fig. We report the isolation and characterization of an alka-
line nuclease mutant engineered to answer a long-stand-8, lane 2). On the other hand, digestion of cytoplasmic
fractions resulted in only resistant DNA, indicating that ing question regarding the structure of the genes com-
prising a 3*-coterminal family of mRNAs from the left endall the cytoplasmic DNA was encapsidated (Fig. 8, lane
3). In Vero cells infected with the mutants AN-1 or AN- of the HSV-1 genome. Although Costa et al. proposed
that a 1.9-kb member of this family may encode an N-F1, the nucleus contains both sensitive and resistant
forms of viral DNA (Fig. 8, lanes 4 and 6, respectively). terminally truncated version of the alkaline nuclease
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gene (UL12) (Costa et al., 1983), this has never been to enhance or modify the enzymatic activity of the cata-
lytic portion of the gene. In this paper we only reportconfirmed. Since the alkaline nuclease genes of HSV-1
and HSV-2 contain approximately 120 amino acids at the exonuclease activity of alkaline nuclease; assays for
endonuclease activity have not been performed in crudetheir N-terminus which are not shared with a large num-
ber of homologues from other herpesviruses (see Fig. 2), extracts. Thus, although no exonuclease activity was de-
tected in crude extracts of cells infected with theit was proposed that the product of the 1.9-kb mRNA
may encode an enzymatically active form of the enzyme frameshift mutants, it is possible that the 60-kDa protein
retains some endonucleolytic activity. Powell and his col-(Costa et al., 1983; McGeoch et al., 1986).
In this report, a frameshift mutant was engineered to leagues have demonstrated an association between the
herpes simplex virus major DNA-binding protein and al-cause the premature termination of translation of the
2.3-kb mRNA corresponding to the full-length alkaline kaline nuclease (Littler et al., 1983; Thomas et al., 1992;
Vaughan et al., 1984). It is possible that protein–proteinnuclease; however, it is not expected to affect the tran-
scription or translation of the 1.9-kb species. Indepen- interactions could cause conformational changes in the
alkaline nuclease which would alter its activity to favordent isolates of the frameshift mutant (AN-F1 and AN-
F3) were compared to KOS and to the null mutant AN-1 either endo- or exonuclease activity. The region of the
alkaline nuclease which interacts with the major DNA-with respect to viral growth and production of RNA and
protein encoded in this region. Several conclusions can binding protein (UL29) has not yet been identified. It is
attractive to speculate that within infected cells, the po-be drawn: (i) The growth properties of the frameshift mu-
tants were identical to those of AN-1. (ii) No alkaline tent exonuclease activity of alkaline nuclease is modified
in some way, thereby avoiding degradation of the repli-nuclease activity could be detected in crude extracts
of cells infected with three independent isolates of the cating viral DNA. It will thus be of considerable interest
to determine whether the UL12.5 protein has any residualframeshift mutation. (iii) In cells infected with KOS and
AN-F1, the predicted five members of the 3*-coterminal enzymatic activity, to map the domains of alkaline
nuclease responsible for protein–protein interactions,family of mRNAs are all present, indicating that the
frameshift mutation did not alter the overall transcription and to determine whether the presence of UL29 or other
viral proteins can alter the activity of purified recombinantpattern from this region. (iv) Northern and immunoblot
experiments showed that in cells infected with KOS, AN- alkaline nuclease in vitro.
We previously showed that the null mutant AN-1 exhib-1, AN-F1, and AN-1-2a, the 0.9-kb UL11 mRNA and UL11
protein are present, indicating that the nuc mutants are its two major differences from wild-type virus, in the abil-
ity of DNA-containing capsids to mature from the nucleusnot defective in the expression of this open reading
frame. (v) Using a sensitive polyclonal antiserum raised into the cytoplasm and in the structure of replicating viral
DNA which accumulates in infected cells (Martinez etagainst recombinant alkaline nuclease, a 60-kDa band
was detected in cells infected with wild-type KOS and al., 1995; Shao et al., 1993). In this paper we have found
that like AN-1, AN-F1 is able to synthesize viral DNA andwith both isolates of the frameshift mutant, AN-F1 and
AN-F3. The 60-kDa band is not as abundant as the full- to carry out cleavage and packaging of viral genomes in
the nucleus. In addition, AN-F1 resembles AN-1 in itslength alkaline nuclease, but its presence indicates that
the 1.9-kb mRNA can encode an N-terminally truncated inability to produce capsids which are competent to ma-
ture into the cytoplasm.version of the alkaline nuclease peptide corresponding
to the UL12.5 open reading frame. The other major difference between AN-1 and wild-
type virus is in the structure of DNA which accumulatesThe role of UL12.5 in viral infection is not clear. Crude
extracts from AN-F1-infected cells do not exhibit detect- in infected cells (Martinez et al., 1995). Severini et al. have
previously reported that HSV-1 replication intermediatesable exonucleolytic activity, although we cannot rule out
that the protein has low levels of activity undetectable in have a complex branched structure (Severini et al., 1994).
We have previously proposed that the HSV-1 alkalinecrude extracts. Given the low levels of expression of
UL12.5 compared to those of full-length UL12, it is possi- nuclease may function as a debranching enzyme which
may function to resolve replication intermediates prior toble that even if UL12.5 possesses normal activity, it may
not have been detected. Alternatively, it is possible that efficient packaging into viral capsids (Shao et al., 1993).
In support of this model are recent results which demon-the N-terminal 126-amino-acid region of UL12 may be
responsible for a function entirely different from nuclease strate that DNA which accumulates in AN-1-infected cells
is more highly branched than that in cells infected withactivity. A precedent for this type of gene organization is
the large subunit of the HSV ribonucleotide reductase in wild-type virus (Martinez et al., 1995). The frameshift mu-
tants behave in a fashion identical to the null mutant withwhich the N-terminal portion contains a domain that has
Ser/Thr-specific protein kinase activity (Chung et al., respect to the structure of viral DNA which accumulates
in infected cells (Martinez et al., 1995). Thus the 60-kDa1989, 1990; Conner et al., 1992; Paradis et al., 1991).
Another possibility is that the N-terminus of alkaline product of the 1.9-kb mRNA (UL12.5 open reading frame)
is not able to substitute effectively for full-length alkalinenuclease may contain a functional region which may act
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synthesis of viral DNA. Virology 116, 116–127.
of HSV-1, a mutant will be constructed in which the pre- Francke, B., Moss, H., Timbury, M. C., and Hay, J. (1978). Alkaline DNase
dicted initiation AUG for translation of the 60-kDa protein activity in cells infected with a temperature-sensitive mutant of her-
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